News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mediomics, LLC Awarded Phase II Grant From National Institutes of Health (NIH): Receives More Than $1M For Rapid Homogenous Protein Assay Platform Development


7/28/2010 8:11:45 AM

ST. LOUIS--(BUSINESS WIRE)--Mediomics, LLC has received an additional $460,000 in a renewal of its 2nd year STTR Phase II grant (R42GM079891) from the National Institute of General Medical Sciences. Since 2007, Mediomics has received over one million dollars of STTR funding to develop its quick and sensitive homogenous PINCERâ„¢ protein assay. The major goal of the second year project is to further increase the sensitivity of the biosensor.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES